Epidemics
Before, during and after an epidemic, it is essential to provide people with trusted, clear and effective information. Engaging with communities can help to prevent fear, panic and rumours from undermining response efforts.
8 April 2025
Strengthening the Community Response to Mpox: Lessons Learned from Feedback in Cameroon
Type:
ReportOrganization:
Cameroon Red Cross, IFRCThis report captures data from community feedback collected by the Cameroon Red Cross in October 2024, in response to the Mpox outbreak. The feedback helped adapt interventions to local needs…
25 March 2025
Viral Haemorrhagic Fevers Question Bank
Type:
ToolOrganization:
Collective Service RCCE, SSHAPThis question bank provides guidance on undertaking social science research in the context of an outbreak of a viral haemorrhagic fever (VHF).
25 March 2025
Cholera Question Bank
Type:
ToolOrganization:
Collective Service RCCEA zip folder containing qualitative and quantitative questions for community-level cholera data collection. This question bank can be used by field teams and/ or local research teams working in communities…
25 March 2025
Mpox Question Bank
Type:
ToolOrganization:
Collective Service RCCE, SSHAPA zip folder containing qualitative and quantitative questions for community-level mpox data collection. This question bank can be used by field teams and/ or local research teams working in communities…
24 March 2025
Cross-border dynamics between Burundi and Tanzania in the context of viral haemorrhagic fever outbreaks, 2025
Type:
ReportOrganization:
SSHAPThis brief summarises key considerations regarding cross-border dynamics between the Republic of Burundi and the United Republic of Tanzania in the context of viral haemorrhagic fever (VHF) outbreaks in Tanzania…
24 March 2025
Using social and behavioural science to inform the use of vaccines during health emergencies
Type:
ReportOrganization:
SSHAPThis brief synthesises social and behavioural science (SBS) research on the use of vaccines during health emergencies in sub-Saharan Africa, including vaccines undergoing clinical trials (‘experimental vaccines’).
Page 2 of 16